-
NRXP Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
NRx Pharmaceuticals (NRXP)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 1.65 mm | 1.65 mm | 1.65 mm | 1.65 mm | 1.65 mm | 1.65 mm |
Cash burn (monthly) | 84.00 k | 604.67 k | 1.01 mm | 1.71 mm | 768.67 k | 977.58 k |
Cash used (since last report) | 235.15 k | 1.69 mm | 2.82 mm | 4.78 mm | 2.15 mm | 2.74 mm |
Cash remaining | 1.41 mm | -46.68 k | -1.17 mm | -3.13 mm | -505.77 k | -1.09 mm |
Runway (months of cash) | 16.8 | -0.1 | -1.2 | -1.8 | -0.7 | -1.1 |
13F holders | Current |
---|---|
Total holders | 35 |
Opened positions | 6 |
Closed positions | 3 |
Increased positions | 6 |
Reduced positions | 5 |
13F shares | Current |
---|---|
Total value | 4.80 bn |
Total shares | 11.14 mm |
Total puts | 4.50 k |
Total calls | 105.80 k |
Total put/call ratio | 0.0 |
Largest owners | Shares | Value |
---|---|---|
Armistice Capital | 5.64 mm | $2.73 bn |
Vanguard | 1.48 mm | $714.69 mm |
Sabby Management | 699.73 k | $338.32 mm |
Big Rock Partners Sponsor | 655.57 k | $15.90 mm |
BRAC Lending | 590.43 k | $14.32 mm |
CVI | 483.57 k | $233.81 mm |
Geode Capital Management | 378.67 k | $183.09 mm |
BLK BlackRock | 290.71 k | $140.56 mm |
RY Royal Bank of Canada | 171.23 k | $83.00 mm |
Bridgeway Capital Management | 160.70 k | $77.70 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
17 Dec 24 | Javitt Jonathan C | Common Stock | Buy | Acquire P | No | No | 1.17 | 40,000 | 46.80 k | 84,634 |